Objectives: This study aimed to assess the real-world rates of treatment discontinuation and switching of biologic therapies in patients with inflammatory bowel disease (IBD). Meth

DataCite Commons2025-04-01 更新110

Supplementary Material for: Does the 5-Aminosalicylate Concentration Correlate with the Efficacy of Oral 5-Aminosalicylate and Predict Response in Patients with Inflammatory Bowel Disease? A Systematic Review

炎症性肠病

用药监测

Background: Oral 5-aminosalicylic acid (5-ASA, mesalazine) is the first choice therapeutic agent for treating mild-to-moderate ulcerative colitis (UC). Unfortunately a significant group

DataCite Commons2020-08-27 更新90

Czech Republic - Prague and South Bohemia Epidemiology Committee Study 2010

资源简介：

相关数据集